Baryshev M, Sargsyan E, Wallin G, Lejnieks A, Furudate S, Hishinuma A, Mkrtchian S
Division of Molecular Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Nobels väg 13, 171 77 Stockholm, Sweden.
J Mol Endocrinol. 2004 Jun;32(3):903-20. doi: 10.1677/jme.0.0320903.
The unfolded protein response (UPR) is an intracellular signaling pathway that regulates the protein folding and processing capacity of the endoplasmic reticulum (ER). The UPR is induced by the pharmacological agents that perturb ER functions but is also activated upon excessive accumulation of the mutant secretory proteins that are unable to attain correct three-dimensional structure and are thus retained in the ER. Such defects in intracellular protein transport underlie the development of a number of phenotypically diverse inherited pathologies, termed endoplasmic reticulum storage diseases (ERSD). We have studied UPR development in two similar ERSDs, human congenital goiter caused by the C1264R and C1996S mutations in the thyroglobulin (Tg) gene and non-goitrous congenital hypothyroidism in rdw dwarf rats determined by the G2320R Tg mutation. In both cases, these mutations rendered Tg incapable of leaving the ER. A major ER chaperone immunoglobulin-binding protein (BiP), and a novel putative escort chaperone endoplasmic reticulum protein 29 KDa (ERp29) were found to be associated with Tg, which might be interpreted as the contribution of the quality control machinery to the previously shown retention of Tg in the ER. We have extended our earlier observations of ER chaperone induction with the identification of the additional ER (ERp29, ERp72, calreticulin, protein disulfide isomerase (PDI)), cytoplasmic (heat shock protein (HSP)70, HSP90) and mitochondrial (mtHSP70) upregulated chaperones and folding enzymes. Activation of the transcriptional arm of UPR, as judged by the appearance of the spliced (active) form of X-box binding protein (XBP1) and processed activating transcription factor 6 (ATF6) transcription factors was suggested to contribute to the overexpression of the ER chaperones. The processing of ATF6 was observed in both human and rat tissues with Tg mutations. Whereas, in human tissues, weak splicing of XBP1 mRNA was detected only in the C1264R mutant, all rat thyroids including wild-type contained significant amounts of the spliced form of XBP1 as opposed to human liver and rat brain tissues, implying the existence of a previously unknown tissue-specific regulation of XBP1 processing.
未折叠蛋白反应(UPR)是一种细胞内信号通路,可调节内质网(ER)的蛋白质折叠和加工能力。UPR可由干扰ER功能的药物诱导,但当无法获得正确三维结构并因此滞留在ER中的突变分泌蛋白过度积累时也会被激活。细胞内蛋白质运输的此类缺陷是许多表型多样的遗传性疾病(称为内质网储存疾病,ERSD)发生的基础。我们研究了两种相似的ERSD中的UPR发展情况,一种是由甲状腺球蛋白(Tg)基因中的C1264R和C1996S突变引起的人类先天性甲状腺肿,另一种是由G2320R Tg突变决定的rdw侏儒大鼠的非甲状腺肿性先天性甲状腺功能减退。在这两种情况下,这些突变使Tg无法离开ER。发现一种主要的ER伴侣蛋白免疫球蛋白结合蛋白(BiP)和一种新的假定护送伴侣蛋白内质网蛋白29 kDa(ERp29)与Tg相关,这可能被解释为质量控制机制对先前显示的Tg滞留在ER中的作用。我们通过鉴定额外的ER(ERp29、ERp72、钙网蛋白、蛋白质二硫键异构酶(PDI))、细胞质(热休克蛋白(HSP)70、HSP90)和线粒体(mtHSP70)上调的伴侣蛋白和折叠酶,扩展了我们早期对ER伴侣蛋白诱导的观察。通过X盒结合蛋白(XBP1)的剪接(活性)形式和加工后的激活转录因子6(ATF6)转录因子的出现判断,UPR转录臂的激活被认为有助于ER伴侣蛋白的过表达。在人和大鼠组织中均观察到了Tg突变时ATF6的加工。然而,在人类组织中,仅在C1264R突变体中检测到XBP1 mRNA的弱剪接,与人类肝脏和大鼠脑组织相反,所有大鼠甲状腺包括野生型都含有大量的XBP1剪接形式,这意味着存在以前未知的XBP1加工的组织特异性调节。